Your browser doesn't support javascript.
loading
A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC.
Lemmon, Christopher A; Videtic, Gregory M M; Murthy, Sudish; Stephans, Kevin L; Shapiro, Marc; Ahmad, Usman; Raymond, Daniel; Velcheti, Vamsidhar; Bribriesco, Alejandro; Jia, Xuefei; Stevenson, James; Pennell, Nathan A.
Afiliação
  • Lemmon CA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Videtic GMM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Murthy S; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio.
  • Stephans KL; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Shapiro M; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Ahmad U; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio.
  • Raymond D; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio.
  • Velcheti V; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Bribriesco A; Present Address: Division of Hematology and Medical Oncology, Perlmutter Cancer Center, New York University Langone School of Medicine, New York, New York.
  • Jia X; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio.
  • Stevenson J; Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio.
  • Pennell NA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
JTO Clin Res Rep ; 3(7): 100359, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35815318

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article